{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:59:55Z","timestamp":1785859195233,"version":"3.56.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1097\/01.ftd.0000189898.23931.3f","type":"journal-article","created":{"date-parts":[[2006,1,17]],"date-time":"2006-01-17T05:16:13Z","timestamp":1137474973000},"page":"95-101","source":"Crossref","is-referenced-by-count":29,"title":["Pharmacokinetics of Mycophenolic Acid and Metabolites in Diabetic Kidney Transplant Recipients"],"prefix":"10.1097","volume":"28","author":[{"given":"Fatemeh","family":"Akhlaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag G","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X Patricia","family":"Zuniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenana","family":"Halilovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido S","family":"Preis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginald Y","family":"Gohh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"S. renal transplant mycophenolate mofetil study group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients.","volume":"60","year":"1995","journal-title":"Transplantation"},{"key":"R2-20-20210129","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/j.1552-4604.1996.tb04207.x","article-title":"pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration.","volume":"36","author":"Bullingham","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"R3-20-20210129","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/clinchem\/41.7.1011","article-title":"Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics.","volume":"41","author":"Nowak","year":"1995","journal-title":"Clin Chem"},{"key":"R4-20-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00007691-200302000-00001","article-title":"Acyl glucuronide drug metabolites: toxicological and analytical implications.","volume":"25","author":"Shipkova","year":"2003","journal-title":"Ther Drug Monit"},{"key":"R5-20-20210129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil.","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 9","key":"R6-20-20210129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-6135.2004.00399.x","article-title":"Kidney and pancreas transplantation.","volume":"4","author":"Wynn","year":"2004","journal-title":"Am J Transplant"},{"key":"R7-20-20210129","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States.","volume":"3","author":"Kasiske","year":"2003","journal-title":"Am J Transplant"},{"key":"R8-20-20210129","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00003088-199120060-00004","article-title":"The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans.","volume":"20","author":"Gwilt","year":"1991","journal-title":"Clin Pharmacokinet"},{"key":"R9-20-20210129","first-page":"1337","article-title":"Long-term diabetes alters the hepatobiliary clearance of acetaminophen, bilirubin and digoxin.","volume":"260","author":"Watkins","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"R10-20-20210129","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/00003088-199019020-00004","article-title":"Disease-induced variations in plasma protein levels, implications for drug dosage regimens (part I).","volume":"19","author":"Zini","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"R11-20-20210129","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0041-1345(98)01948-4","article-title":"Comparison of MPA trough levels in patients with severe diabetes mellitus and from non-diabetics after transplantation.","volume":"31","author":"Zanker","year":"1999","journal-title":"Transplant Proc"},{"key":"R12-20-20210129","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1046\/j.1600-6135.2003.00243.x","article-title":"Equivalent pharmacokinetics of mycophenolate mofetil in African-American and Caucasian male and female stable renal allograft recipients.","volume":"3","author":"Pescovitz","year":"2003","journal-title":"Am J Transplant"},{"key":"R13-20-20210129","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00007691-200412000-00006","article-title":"Mycophenolic acid in diabetic renal transplant recipients: pharmacokinetics and application of a limited sampling strategy.","volume":"26","author":"van Hest","year":"2004","journal-title":"Ther Drug Monit"},{"key":"R14-20-20210129","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jchromb.2004.11.046","article-title":"Development and validation of an HPLC-UV method for determination of iohexol in human plasma.","volume":"816","author":"Soman","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R15-20-20210129","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1023\/A:1011935603893","article-title":"How useful is paracetamol absorption as a marker of gastric emptying? A systematic literature study.","volume":"46","author":"Willems","year":"2001","journal-title":"Dig Dis Sci"},{"key":"R16-20-20210129","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jchromb.2004.10.004","article-title":"Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry.","volume":"813","author":"Patel","year":"2004","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R18-20-20210129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0378-4347(99)00290-X","article-title":"Simple and rapid assay for acetaminophen and conjugated metabolites in low-volume serum samples.","volume":"732","author":"Brunner","year":"1999","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"R20-20-20210129","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1023\/A:1026155822121","article-title":"Comparison of the rates of disintegration, gastric emptying, and drug absorption following administration of a new and a conventional paracetamol formulation, using gamma scintigraphy.","volume":"20","author":"Kelly","year":"2003","journal-title":"Pharm Res"},{"key":"R21-20-20210129","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/00007890-199804270-00019","article-title":"Decreased protein binding of mycophenolic acid associated with leukopenia in a pancreas transplant recipient with renal failure.","volume":"65","author":"Kaplan","year":"1998","journal-title":"Transplantation"},{"key":"R22-20-20210129","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2165\/00003088-199019030-00005","article-title":"Disease-induced variations in plasma protein levels, implications for drug dosage regimens (part II).","volume":"19","author":"Zini","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"R23-20-20210129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1248\/bpb.17.16","article-title":"Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism.","volume":"17","author":"Okabe","year":"1994","journal-title":"Biol Pharm Bull"},{"key":"R24-20-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1124\/dmd.104.001651","article-title":"Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.","volume":"33","author":"Picard","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"R25-20-20210129","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/bj3360587","article-title":"Molecular basis of bilirubin UDP-glucuronosyltransferase induction in spontaneously diabetic rats, acetone-treated rats and starved rats.","volume":"336","author":"Braun","year":"1998","journal-title":"Biochem J"},{"key":"R26-20-20210129","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.103.063073","article-title":"Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by Mrp2 in rats.","volume":"309","author":"Kobayashi","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R27-20-20210129","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1034\/j.1600-6143.2003.00079.x","article-title":"Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.","volume":"3","author":"Shaw","year":"2003","journal-title":"Am J Transplant"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003453-199942030-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:07:26Z","timestamp":1785856046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200602000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.ftd.0000189898.23931.3f","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}